General Information of Drug (ID: DMPGTC8)

Drug Name
COR588
Indication
Disease Entry ICD 11 Status REF
Alzheimer disease 8A20 Phase 1 [1]
Drug Type
Small molecule
Cross-matching ID
TTD ID
D62XNL

References

1 ClinicalTrials.gov (NCT04920903) A Phase 1, Randomized, Double-Blind, Placebo-Controlled, First-in-Human, Single- and Multiple-Ascending Dose Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Oral COR588 in Healthy Adult Subjects. U.S.National Institutes of Health.